Literature DB >> 3893809

Phaeochromocytoma.

P E Cryer.   

Abstract

Phaeochromocytomas are uncommon among patients with hypertension, and sometimes occur in persons without known hypertension, but are important to detect because they are often lethal but commonly curable, and because they are a clue to the presence of associated conditions. Paroxysmal symptoms (especially headache, palpitations, diaphoresis and anxiety), hypertension that is intermittent, unusually labile or resistant to conventional therapy, and conditions known to be associated raise the clinical suspicion of phaeochromocytoma. Biochemical confirmation is commonly achieved by measurement of urinary catecholamines, metanephrines or VMA. Plasma noradrenaline and adrenaline measurements may be superior to measurements of urinary catecholamine metabolites, but strict attention to the details of sample collection, handling and storage, the many sources of possible biological variation and the effects of drugs is critical if diagnostic error is to be avoided. Patients should be evaluated in the drug-free state if at all possible. Anatomical localization, in the abdomen in the vast majority of cases and usually in the adrenal medullae, can generally be accomplished with computed tomographic scans. Bilateral adrenomedullary tumours are the rule in familial phaeochromocytoma. Most phaeochromocytomas are benign and can be excised totally after medical preparation with an alpha-adrenergic antagonist.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3893809     DOI: 10.1016/s0300-595x(85)80070-0

Source DB:  PubMed          Journal:  Clin Endocrinol Metab        ISSN: 0300-595X


  10 in total

Review 1.  Pheochromocytoma.

Authors:  P E Cryer
Journal:  West J Med       Date:  1992-04

2.  Diabetes mellitus as presenting feature in extra-adrenal pheochromocytoma: report of a case.

Authors:  P G Balestrieri; S Spandrio; G Romanelli; G Giustina
Journal:  Acta Diabetol Lat       Date:  1990 Jul-Sep

Review 3.  Diagnostic problems in pheochromocytoma.

Authors:  M Mannelli
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

Review 4.  Anaesthesia for phaeochromocytoma.

Authors:  J Pullerits; S Ein; J W Balfe
Journal:  Can J Anaesth       Date:  1988-09       Impact factor: 5.063

5.  Scintigraphy of incidentally discovered bilateral adrenal masses.

Authors:  M D Gross; B Shapiro; I R Francis; R L Bree; M Korobkin; M K McLeod; N W Thompson; J A Sanfield
Journal:  Eur J Nucl Med       Date:  1995-04

6.  Transient cardiogenic shock during a crisis of pheochromocytoma triggered by high-dose exogenous corticosteroids.

Authors:  Majd Ibrahim; Sandeep Banga; Suneetha Venkatapuram; Sudhir Mungee
Journal:  BMJ Case Rep       Date:  2015-02-18

7.  Pediatric pheochromocytoma. A 36-year review.

Authors:  S H Ein; J Pullerits; R Creighton; J W Balfe
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

8.  Cardiomyopathy due to pheochromocytoma.

Authors:  P Kounatiadis; V Kolettas; A Megarisiotou; I Stiliadis
Journal:  Herz       Date:  2013-09-27       Impact factor: 1.443

9.  A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case.

Authors:  M Mannelli; C Pupilli; R Lanzillotti; L Ianni; A Amorosi; G Credi; C Pratesi
Journal:  J Endocrinol Invest       Date:  1993-11       Impact factor: 4.256

10.  Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma.

Authors:  M Mannelli; M L De Feo; M Maggi; C Pupilli; G Opocher; T Valenza; E Baldi; M Serio
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.